Etanercept and efalizumab for the treatment of adults with psoriasis
NHS Quality Improvement Scotland
Record ID 32006001535
English
Details
Project Status:
Completed
URL for project:
http://www.nhshealthquality.org
Year Published:
2006
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Scotland
MeSH Terms
- Adult
- Etanercept
- Psoriasis
- Treatment Outcome
- Drug Therapy, Combination
- Antibodies, Monoclonal
- Dermatologic Agents
- Receptors, Tumor Necrosis Factor
- Recombinant Fusion Proteins
- Tumor Necrosis Factor-alpha
Contact
Organisation Name:
Quality Improvement Scotland
Contact Address:
Delta House, 50 West Nile Street Glasgow G1 2NP Scotland United Kingdom Tel: +44 141 225 6988; Fax: +44 141 221 3262
Contact Name:
shtg.hcis@nhs.net
Contact Email:
shtg.hcis@nhs.net
Copyright:
NHS Quality Improvement Scotland (NHS QIS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.